These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1087232)

  • 21. Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts.
    Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RR; Schretlen ED; van Laarhoven JP; De Bruyn CH
    Biochem Pharmacol; 1986 Oct; 35(20):3549-55. PubMed ID: 2429667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.
    Rivera G; Dahl GV; Bowman WP; Avery TL; Wood A; Aur RJ
    Cancer; 1980 Oct; 46(8):1727-30. PubMed ID: 6932995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multiple agent cyclic chemotherapy in the treatment of acute lymphoblastic leukemia of children ("C"-protocol) (author's transl)].
    Ortega Aramburu JJ; Javier G; Sáenz A; Tusell J
    An Esp Pediatr; 1976 Jun; 9(4 Suppl):49-54. PubMed ID: 782307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of the effect of cytostatic therapy on the T- and B-cell population of peripheral blood in lymphocytic leukemia].
    Tsveĭbakh AS; Gol'dman EI
    Ter Arkh; 1978; 50(7):46-9. PubMed ID: 309667
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Schmiegelow K; Heyman M; Kristinsson J; Mogensen UB; Rosthøj S; Vettenranta K; Wesenberg F; Saarinen-Pihkala U;
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):385-92. PubMed ID: 19648786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of immunosuppressive drugs on T and B lymphocytes in guinea pigs.
    Winkelstein A
    Blood; 1977 Jul; 50(1):81-91. PubMed ID: 301410
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunologic types of lymphocytes in acute lymphatic leukemia during remission (author's transl)].
    Winterleitner H; Palencia C; Knapp W; Eibl M; Krepler P
    Padiatr Padol; 1975; 10(3):237-43. PubMed ID: 1081665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequestration of PHA-responsive cells (T-lymphocytes) in the bone marrow of leukemic children undergoing long-term immunosuppressive therapy.
    Borella L; Green AA
    J Immunol; 1972 Nov; 109(5):927-32. PubMed ID: 4538718
    [No Abstract]   [Full Text] [Related]  

  • 29. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
    Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW
    J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [6-Mercaptopurine and methotrexate, rational use in sight after 35 years?].
    Bökkerink JP; Schouten TJ; De Abreu RA; Lippens RJ; De Vaan GA; De Bruyn CH; Van Laarhoven JP
    Tijdschr Kindergeneeskd; 1984 Aug; 52(4):118-23. PubMed ID: 6593896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of acute lymphoblastic leukemia].
    Paolucci G; Rosito P
    Minerva Pediatr; 1971 Nov; 23(44):1851-69. PubMed ID: 4950250
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.
    Br Med J; 1971 Oct; 4(5781):189-94. PubMed ID: 4940157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of acute lymphoid leukemia in children: current regimens and future prospects.
    Brecher ML
    N Y State J Med; 1986 Apr; 86(4):188-96. PubMed ID: 3520409
    [No Abstract]   [Full Text] [Related]  

  • 34. Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes.
    da Silva CP; de Oliveira CR; da Conceição M; de Lima P
    Biochem Pharmacol; 1996 May; 51(10):1331-40. PubMed ID: 8787549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of continuous or discontinuous maintenance therapy on subsequent remission maintenance in childhood leukemia.
    Lane DM; George SL; Komp D; Lonsdale D; Pullen J; Ragab A; Starling KA
    Cancer; 1977 Nov; 40(5):2005-9. PubMed ID: 336174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance therapy of childhood acute lymphoblastic leukemia revisited-Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?
    Schmiegelow K; Nersting J; Nielsen SN; Heyman M; Wesenberg F; Kristinsson J; Vettenranta K; Schrøeder H; Weinshilboum R; Jensen KL; Grell K; Rosthoej S
    Pediatr Blood Cancer; 2016 Dec; 63(12):2104-2111. PubMed ID: 27447547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired lymphocyte transformation in leukemic patients after intensive therapy.
    Humphrey GB; Nesbit ME; Chary KK; Krivit W
    Cancer; 1972 Feb; 29(2):402-6. PubMed ID: 4501699
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on the immune status of children with acute lymphocytic leukaemia. I. Early phase before and after first remission.
    Hitzig WH; Plüss HJ; Joller P; Pilgrim U; Tacier-Eugster H; Jakob M
    Clin Exp Immunol; 1976 Dec; 26(3):403-13. PubMed ID: 1087593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient appearance of HLA-DRw-positive leukocytes in peripheral blood after cessation of antileukemia therapy.
    Casper JT; Duquesnoy RJ; Borella L
    Transplant Proc; 1980 Mar; 12(1):130-3. PubMed ID: 6154351
    [No Abstract]   [Full Text] [Related]  

  • 40. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
    Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
    Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.